Generating evidence to inform policy and practice: the example of the second generation "atypical" antipsychotics.
The introduction of the second generation "atypical" antipsychotics has been heralded as a major advance in the treatment of schizophrenia and other psychotic disorders. Systematic reviews have revealed only modest advantages over conventional antipsychotics and uncertainty about long-term...
| Main Author: | |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2003
|